Detalles de la búsqueda
1.
Skilful precipitation nowcasting using deep generative models of radar.
Nature
; 597(7878): 672-677, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34588668
2.
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
Br J Haematol
; 204(1): 191-205, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011941
3.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Blood
; 139(5): 732-747, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34653238
4.
Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence as single agent and in combination therapy.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721745
5.
Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.
Haematologica
; 107(11): 2685-2697, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484662
6.
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Blood
; 131(22): 2413-2425, 2018 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449275
7.
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models.
Haematologica
; 105(11): 2584-2591, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131247
8.
The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models.
Haematologica
; 104(8): 1633-1639, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733273
9.
In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103.
Br J Haematol
; 200(5): 669-672, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484636
10.
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
Blood
; 125(12): 1922-31, 2015 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25612624
11.
Amperometric detection in the presence of carbon nanotubes dispersed in background electrolyte: Evaluating its suitability for capillary electrokinetic chromatography separations of polyphenolic compounds.
Electrophoresis
; 36(16): 1945-52, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033384
12.
Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.
Blood
; 119(3): e9-e21, 2012 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22110251
13.
Classification of Spanish white wines using their electrophoretic profiles obtained by capillary zone electrophoresis with amperometric detection.
Electrophoresis
; 35(11): 1693-700, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24585496
14.
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.
Haematologica
; 104(7): e307-e309, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679329
15.
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.
Haematologica
; 104(12): e558-e561, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31018978
16.
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study.
Clin Lymphoma Myeloma Leuk
; 24(4): 224-231.e2, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212206
17.
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Mol Cancer Ther
; 23(3): 368-380, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38052765
18.
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation.
Br J Haematol
; 181(1): 129-133, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28025833
19.
Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.
Mod Pathol
; 26(7): 889-901, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23429603
20.
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors.
J Clin Med
; 12(2)2023 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675328